Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (stock abbreviation: Jiuzhou Pharmaceutical, stock code: 603456. SH), founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading innovative drug CDMO enterprise in the world. It provides global pharmaceutical companies with one-stop drug research and development, production solutions, and professional services from preclinical CMC, clinical phases I, II, and III, NDA to commercial listing of innovative drugs, Established a successful example of transforming traditional generic raw material pharmaceutical enterprises in China into innovative drug CDMO enterprises. As a leader in green pharmaceutical innovation technology, Jiuzhou Pharmaceutical possesses cutting-edge green pharmaceutical technology with independent intellectual property rights, providing industry-leading technological solutions to customers, improving research and development efficiency and success rate, and reducing research and development costs. Caring for life and maintaining health. Jiuzhou Pharmaceutical is committed to becoming an outstanding life and health enterprise in global drug innovation solutions, continuously empowering partners to accelerate the process of innovative drug launch and benefit patients worldwide. |
| Headquarter | Taizhou |
| Establish Date | 7/13/1998 |
| Listed Code | 603456.SH |
| Listed Date | 10/10/2014 |
| Chairman | Hua Lirong. |
| CEO | Mei Yijiang. |
| Website | www.jiuzhoupharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
